Strategies for designing synthetic immune agonists

Abstract

SummaryEnhancing the immune system is a validated strategy to combat infectious disease, cancer and allergy. Nevertheless, the development of immune adjuvants has been hampered by safety concerns. Agents that can stimulate the immune system often bear structural similarities with pathogen-associated molecular patterns found in bacteria or viruses and are recognized by pattern recognition receptors (PRRs). Activation of these PRRs results in the immediate release of inflammatory cytokines, up-regulation of co-stimulatory molecules, and recruitment of innate immune cells. The distribution and duration of these early inflammatory events are crucial in the development of antigen-specific adaptive immunity in the forms of antibody and/or T cells capable of searching for and destroying the infectious pathogens or cancer cells. However, systemic activation of these PRRs is often poorly tolerated. Hence, different strategies have been employed to modify or deliver immune agonists in an attempt to control the early innate receptor activation through temporal or spatial restriction. These approaches include physicochemical manipulation, covalent conjugation, formulation and conditional activation/deactivation. This review will describe recent examples of discovery and optimization of synthetic immune agonists towards clinical application.

The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery

“…First, the oral administrations of statins (as applied in general populations) would not generate an optimized environment pertinent to strong immune activations-optimized environments are often in peripheral/ parenchymal tissues rather than in gastrointestinal tracts. Second, in light of our findings that lipophilic, but not polar statins (and bisphosphonates), confer significant adjuvant effects, the temporal accumulation of a locally concentrated adjuvant in combination with antigens appears to be essential to induce adaptive immune responses (Wu, 2016).…”

Significance and Role of Pattern Recognition Receptors in Malignancy

“…With the increasing knowledge of structure, and function of natural products and innate receptor biology, researchers managed to synthesize novel simplified substances using tools of modern chemistry, that mimic natural PRRs ligands. Several of them possess properties of immune adjuvants, able to stimulate antigen-presenting cells, when applied topically with antigen as a vaccine (Li et al 2017a; Mikulandra et al 2017; Wu 2016). Several synthetic PRR ligands were produced, most of them for TLRs (Wu 2016).…”

Therapeutic Targeting of RIG-I and MDA5 Might Not Lead to the Same Rome

“…This approach would be worth testing with MDA5 ligands in preclinical studies. However, the application of these strategies to specifically engage RLRs in human trials remains challenging [74].…”